Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Wondwossen A. Gebreyes

Wondwossen A. Gebreyes

Director and Professor
Global Health Programs
Department of Veterinary Preventive Medicine
Ohio State University
USA

Biography

Gebreyes is professor of molecular epidemiology, Director of Global Health Programs at The Ohio State University, College of Veterinary Medicine and Chair of the Ohio State Ethiopia One Health Task Force. He is a native of Ethiopia and naturalized citizen of the United States. He completed his Doctor of Veterinary Medicine (DVM) at Addis Ababa University and completed his PhD at North Carolina State University. Dr. Gebreyes is the principal investigator of the National institute of Health (NIH) Fogarty International Center, Global Infectious Diseases, research and training program on Molecular epidemiology of Foodborne pathogens for eastern Africa including Ethiopia, Kenya and Tanzania. He is engaged in various global capacity building efforts including teaching annual course on molecular epidemiology of infectious diseases in Brazil and Ethiopia. He also directs the Infectious Diseases Molecular Epidemiology Laboratory (IDMEL). IDMEL has a major goal and activity investigating molecular mechanisms of multi-drug resistance in gram-negative organisms. He is a recipient of several awards including the Battelle Endowment for Technology and Human Affairs (BETHA); Pfizer Research Award; American Society of Microbiology (ASM) International professorship award among others.

Research Interest

infectious diseases epidemiology, zoonoses, public health at the human animal interface, livestock biotechnology, antimicrobial resistance and molecular epidemiology in food borne (including Salmonella, Campylobacter and Yersinia); nosocomial and community acquired (including Methicillin resistant Staphylococcus aureus and Hypervirulent Clostridium difficile) infections.